Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer

NCT02257775 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT02257775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02257775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Observational
Overall status
Terminated
Start date
May 11, 2015
Completion date
November 23, 2017
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer